Singapore, April 12 -- Singapore's 'Terumo Blood and Cell Technologies' has announced its Asia Pacific Advanced Therapy Manufacturing & Innovation (ATMI) Grant Winner from Seoul National University College.

Dr. Chung-Gyu Park, a professor at South Korea's Seoul National University College of Medicine, is the winner of the Advanced Therapy Manufacturing and Innovation (ATMI) Grant 2020 for the Asia Pacific region. Terumo Blood and Cell Technologies offered the USD 50,000 ATMI Grant 2020 to promote advanced cell therapy manufacturing and development in the Asia Pacific region to support the creative exploration of novel applications with the Quantum(R) Cell Expansion System.

Terumo Blood and Cell Technologies is a global leader offering d...